{
  "id": 19382598,
  "title": "Mirum plans FDA submission for hepatitis D treatment as competition brews",
  "url": "https://urgent.news/2026/11/10/mirum-plans-fda-submission-for-hepatitis-d-treatment-as-competition",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-10T19:31:21.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/mirum-plans-fda-submission-for-hepatitis-d-treatment-as-competition-brews/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Mirum’s hepatitis D treatment has succeeded in the second of two pivotal trials. Now comes the next challenge: competing with rivals in a growing market. The Phase 3 trial, called AZURE-4, enrolled 113 treatment-naïve patients ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}